Antitrust Antitrust

Bausch, Lupin ask California judge to rule against lawsuits alleging Glumetza pay-for-delay deal

By Michael Acton
  • 22 Apr 2021 16:10
  • 22 Apr 2021 17:09
Bausch, Lupin and Assertio appeared before a California federal judge today at a hearing on a spree of antitrust lawsuits claiming the companies used an unlawful "pay-for-delay" deal to prevent generic versions of the diabetes drug Glumetza from going to market.

US District Judge William Alsup of the Northern District of California

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

LEARN MORE LEARN MORE

Latest News